Tevogen Bio Expands on Microsoft Partnership to Integrate Machine Learning and AI into Preclinical Processes, Accelerating Drug Development and Reducing Costs

31/10/2024 - 22:54

Current timeline for drug development is 10-12 years and costs approximately $1-3 billion. Tevogen’s approach has the potential to shorten timelines and substantially reduce costs.

Tevogen’s AI initiative, Tevogen.AI, will pursue two key objectives, applying machine learning to existing processes to accelerate drug development and lower costs, and using Microsoft’s industry leading AI tools to develop proprietary algorithms designed to decode the relationship between genetics and T cells.